DHR: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/4e9daf8c-6bd8-4cf2-acba-dfcad3f3bda0/","filing_uuid":"4e9daf8c-6bd8-4cf2-acba-dfcad3f3bda0","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/4e9daf8c-6bd8-4cf2-acba-dfcad3f3bda0/print/","filing_document_content_type":"text/html","income":null,"expenses":"190000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Mayealie Adams","dt_posted":"2026-10-20T15:43:43-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2200 Pennsylvania Ave., NW","registrant_address_2":"STE 801E","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":401107157,"url":"https://lda.gov/api/v1/registrants/401107157/","house_registrant_id":55855,"name":"DANAHER CORPORATION","description":null,"address_1":"2200 Pennsylvania Ave., NW","address_2":"STE 801E","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAYEALIE ADAMS","contact_telephone":"+1 202-571-4075","dt_updated":"2026-07-27T22:57:42.247214-04:00"},"client":{"id":53729,"url":"https://lda.gov/api/v1/clients/53729/","client_id":53729,"name":"DANAHER CORPORATION","general_description":"health care products developer and manufacturer","client_government_entity":null,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-11-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to biotechnology, cell and gene therapy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140891,"prefix":null,"prefix_display":null,"first_name":"MAYEALIE","nickname":null,"middle_name":null,"last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"General issues related to tariffs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140891,"prefix":null,"prefix_display":null,"first_name":"MAYEALIE","nickname":null,"middle_name":null,"last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}